(VIANEWS) – Shares of Pacific Biosciences of California (NASDAQ: PACB) rose by a staggering 21.63% in 7 days from $4.68 to $5.69 at 15:18 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ is jumping 2.31% to $11,931.64, following the last session’s downward trend.

Pacific Biosciences of California’s last close was $5.51, 84.85% under its 52-week high of $36.36.

Volume

Today’s last reported volume for Pacific Biosciences of California is 4028501 which is 36.15% below its average volume of 6309351.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 33.8% for the current quarter and 48.3% for the next. The company’s growth estimates for the ongoing quarter is a negative 178.4% and positive 40% for the next.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Volatility

Pacific Biosciences of California’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.91%, a negative 1.69%, and a positive 5.92%, respectively.

Pacific Biosciences of California’s highest amplitude of average volatility was 11.03% (last week), 6.31% (last month), and 5.92% (last quarter), respectively.

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.69 at 15:18 EST, way under its 52-week high of $36.36 and way higher than its 52-week low of $4.51.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way under its 50-day moving average of $8.33 and way under its 200-day moving average of $18.79.

More news about Pacific Biosciences of California (PACB).

LEAVE A REPLY

Please enter your comment!
Please enter your name here